Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study

转运蛋白 横断面研究 医学 重性抑郁障碍 内科学 炎症 病理 神经炎症 扁桃形结构
作者
Elaine Setiawan,Sophia Attwells,Alan A. Wilson,Romina Mizrahi,Pablo Rusjan,Laura Miler,Cynthia Xu,Sarita Sharma,Stephen J. Kish,Sylvain Houle,Jeffrey H. Meyer
出处
期刊:The Lancet Psychiatry [Elsevier]
卷期号:5 (4): 339-347 被引量:202
标识
DOI:10.1016/s2215-0366(18)30048-8
摘要

Summary

Background

People with major depressive disorder frequently exhibit increasing persistence of major depressive episodes. However, evidence for neuroprogression (ie, increasing brain pathology with longer duration of illness) is scarce. Microglial activation, which is an important component of neuroinflammation, is implicated in neuroprogression. We examined the relationship of translocator protein (TSPO) total distribution volume (VT), a marker of microglial activation, with duration of untreated major depressive disorder, and with total illness duration and antidepressant exposure.

Methods

In this cross-sectional study, we recruited participants aged 18–75 years from the Toronto area and the Centre for Addiction and Mental Health (Toronto, ON, Canada). Participants either had major depressive episodes secondary to major depressive disorder or were healthy, as confirmed with a structured clinical interview and consultation with a study psychiatrist. To be enrolled, participants with major depressive episodes had to score a minimum of 17 on the 17-item Hamilton Depression Rating Scale, and had to be medication free or taking a stable dose of medication for at least 4 weeks before PET scanning. Eligible participants were non-smokers; had no history of or concurrent alcohol or substance dependence, neurological illness, autoimmune disorder, or severe medical problems; and were free from acute medical illnesses for the previous 2 weeks before PET scanning. Participants were excluded if they had used brain stimulation treatments within the 6 months before scanning, had used anti-inflammatory drugs lasting at least 1 week within the past month, were taking hormone replacement therapy, had psychotic symptoms, had bipolar disorder (type I or II) or borderline antisocial personality disorder, or were pregnant or breastfeeding. We scanned three primary grey-matter regions of interest (prefrontal cortex, anterior cingulate cortex, and insula) and 12 additional regions and subregions using 18F-FEPPA PET to measure TSPO VT. We investigated the duration of untreated major depressive disorder, and the combination of total duration of disease and duration of antidepressant treatment, as predictor variables of TSPO VT, assessing their significance.

Findings

Between Sept 1, 2009, and July 6, 2017, we screened 134 participants for eligibility, of whom 81 were included in the study (current major depressive episode n=51, healthy n=30). We excluded one participant with a major depressive episode from the analysis because of unreliable information about previous medication use. Duration of untreated major depressive disorder was a strong predictor of TSPO VT (p<0·0001), as were total illness duration (p=0·0021) and duration of antidepressant exposure (p=0·037). The combination of these predictors accounted for about 50% of variance in TSPO VT in the prefrontal cortex, anterior cingulate cortex, and insula. In participants who had untreated major depressive disorder for 10 years or longer, TSPO VT was 29–33% greater in the prefrontal cortex, anterior cingulate cortex, and insula than in participants who were untreated for 9 years or less. TSPO VT was also 31–39% greater in the three primary grey-matter regions of participants with long duration of untreated major depressive disorder compared with healthy participants (p=0·00047).

Interpretation

Microglial activation, as shown by TSPO VT, is greater in patients with chronologically advanced major depressive disorder with long periods of no antidepressant treatment than in patients with major depressive disorder with short periods of no antidepressant treatment, which is strongly suggestive of a different illness phase. Consistent with this, the yearly increase in microglial activation is no longer evident when antidepressant treatment is given.

Funding

Canadian Institutes of Health Research and Neuroscience Catalyst Fund.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
开心绿柳发布了新的文献求助10
刚刚
蓝桉发布了新的文献求助30
刚刚
Ahuang发布了新的文献求助10
刚刚
所所应助研友_08ozgZ采纳,获得10
1秒前
蓬荜生辉完成签到,获得积分10
1秒前
1秒前
雪雪儿完成签到,获得积分10
1秒前
陈钱罐发布了新的文献求助10
1秒前
linfangfang发布了新的文献求助10
1秒前
科研通AI2S应助研友_8YoVDn采纳,获得10
2秒前
xjcy应助阿文采纳,获得10
3秒前
3秒前
3秒前
汉堡包应助感性的不惜采纳,获得10
3秒前
梅倪发布了新的文献求助10
3秒前
4秒前
5秒前
6秒前
lingling完成签到 ,获得积分10
6秒前
清秀的砖头完成签到,获得积分10
7秒前
空格TNT发布了新的文献求助10
8秒前
研友_8Qqy48完成签到,获得积分10
8秒前
舒心绝义发布了新的文献求助10
8秒前
天南发布了新的文献求助10
9秒前
9秒前
Johnwick完成签到,获得积分10
9秒前
acffo完成签到 ,获得积分10
10秒前
迷路海蓝应助kingmo采纳,获得10
10秒前
张亮完成签到,获得积分10
10秒前
梅倪完成签到,获得积分10
11秒前
婷妞儿完成签到,获得积分10
11秒前
祖问筠完成签到,获得积分10
11秒前
WXX发布了新的文献求助10
11秒前
克林发布了新的文献求助10
11秒前
11秒前
Inspiring完成签到,获得积分10
12秒前
橙子发布了新的文献求助10
12秒前
隐形曼青应助Momo采纳,获得10
13秒前
leekle完成签到,获得积分10
13秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3144189
求助须知:如何正确求助?哪些是违规求助? 2795795
关于积分的说明 7816709
捐赠科研通 2451879
什么是DOI,文献DOI怎么找? 1304729
科研通“疑难数据库(出版商)”最低求助积分说明 627286
版权声明 601419